2009
DOI: 10.1021/pr801111a
|View full text |Cite
|
Sign up to set email alerts
|

Identifying Candidate Serum Biomarkers of Exposure to Tunicamycins in Rats Using Two-Dimensional Electrophoresis

Abstract: A model for chronic corynetoxins poisoning has been established in rats exposed to the toxicologically bioequivalent inhibitor of N-linked glycosylation the tunicamycins. Consumption of corynetoxins in contaminated pasture can result in the often fatal neurological disease of grazing livestock annual ryegrass toxicity (ARGT). Corynetoxins may also threaten human health as potential contaminants of the food supply via grain or products derived from subclinically exposed animals. The serum proteomes of four dose… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
2
0

Year Published

2012
2012
2012
2012

Publication Types

Select...
4

Relationship

1
3

Authors

Journals

citations
Cited by 4 publications
(2 citation statements)
references
References 53 publications
0
2
0
Order By: Relevance
“…Mass spectrometry was carried out on an 1100 series HPLC system (Agilent Technologies, Inc., Santa Clara, CA, USA) coupled to a HCT Ultra 3D-Ion-Trap mass spectrometer (Bruker Daltonik GmbH, Bremen, Germany) as described previously [28]. …”
Section: Methodsmentioning
confidence: 99%
“…Mass spectrometry was carried out on an 1100 series HPLC system (Agilent Technologies, Inc., Santa Clara, CA, USA) coupled to a HCT Ultra 3D-Ion-Trap mass spectrometer (Bruker Daltonik GmbH, Bremen, Germany) as described previously [28]. …”
Section: Methodsmentioning
confidence: 99%
“…A model for chronic corynetoxin poisoning has been established in rats with the use of the toxicological bioequivalent tunicamycin. Dietary exposure up to 12 months results in the differential regulation of 14 serum proteins [40]. Of special interest, in view of the primary effect of tunicamycin as inhibitor of N-linked glycosylation, is the finding of carbohydrate-deficient transferrin, whose level increases in a dose-and time-dependent fashion following treatment.…”
mentioning
confidence: 99%